HR
PFE icon

Hardy Reed’s Pfizer PFE Stock Holding History

Hardy Reed’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$299K Buy
10,650
+624
+6% +$16.6K 0.02% 190
2025
Q4 		$250K Buy
10,026
+243
+2% +$6.13K 0.02% 210
2025
Q3 		$249K Buy
9,783
+603
+7% +$14.9K 0.02% 212
2025
Q2 		$223K Buy
+9,180
New +$214K 0.02% 230
2024
Q4 		– Sell
-11,133
Closed -$322K – 257
2024
Q3 		$322K Buy
11,133
+1,578
+17% +$46K 0.03% 180
2024
Q2 		$267K Buy
9,555
+826
+9% +$22.7K 0.03% 198
2024
Q1 		$242K Sell
8,729
-236
-3% -$6.55K 0.03% 104
2023
Q4 		$258K Sell
8,965
-219
-2% -$6.62K 0.04% 104
2023
Q3 		$305K Sell
9,184
-103
-1% -$3.64K 0.06% 80
2023
Q2 		$341K Sell
9,287
-247
-3% -$9.61K 0.06% 70
2023
Q1 		$389K Sell
9,534
-322
-3% -$13.9K 0.07% 74
2022
Q4 		$505K Sell
9,856
-45
-0.5% -$2.16K 0.1% 57
2022
Q3 		$433K Hold
9,901
– – 0.1% 48
2022
Q2 		$519K Sell
9,901
-88
-0.9% -$4.48K 0.11% 42
2022
Q1 		$517K Buy
9,989
+636
+7% +$33K 0.1% 43
2021
Q4 		$552K Hold
9,353
– – 0.09% 52
2021
Q3 		$402K Sell
9,353
-370
-4% -$16.4K 0.07% 68
2021
Q2 		$381K Sell
9,723
-30
-0.3% -$1.17K 0.07% 66
2021
Q1 		$353K Sell
9,753
-30
-0.3% -$1.06K 0.07% 67
2020
Q4 		$360K Sell
9,783
-528
-5% -$19.4K 0.08% 69
2020
Q3 		$359K Buy
10,311
+780
+8% +$27.3K 0.09% 56
2020
Q2 		$296K Sell
9,531
-81
-0.8% -$2.75K 0.11% 56
2020
Q1 		$298K Buy
9,612
+1,334
+16% +$45.5K 0.14% 45
2019
Q4 		$308K Buy
8,278
+713
+9% +$25.4K 0.11% 52
2019
Q3 		$258K Buy
7,565
+201
+3% +$7.31K 0.1% 52
2019
Q2 		$303K Sell
7,364
-93
-1% -$3.69K 0.12% 49
2019
Q1 		$300K Hold
7,457
– – 0.11% 47
2018
Q4 		$309K Buy
+7,457
New +$310K 0.13% 44

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Hardy Reed's PFE Position: Q1 2026 in Review

Hardy Reed increased its Pfizer (PFE) stake by 6.2% in Q1 2026, buying an estimated $16.6K and bringing the position to 10,650 shares worth $299K. The position accounts for 0.02% of the portfolio, ranked #190.

Hardy Reed first reported a position in PFE in Q4 2018 and has held it in 28 quarters since. The position peaked at $552K in Q4 2021. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Hardy Reed held 10,650 shares of Pfizer worth $299K as of Q1 2026.
  • Hardy Reed bought 624 Pfizer shares in Q1 2026, an estimated $16.6K.
  • Pfizer made up 0.02% of Hardy Reed's portfolio in Q1 2026, its #190 holding.
  • Hardy Reed first reported a position in Pfizer in Q4 2018 and has held it in 28 quarters since.
  • Hardy Reed's Pfizer position peaked at $552K in Q4 2021.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Hardy Reed's 13F filing for Q1 2026, filed 28 Apr 2026.